Market capitalization | SEK8.12b |
Enterprise Value | SEK7.51b |
P/E (TTM) P/E ratio | 56.25 |
EV/FCF (TTM) EV/FCF | 134.24 |
EV/Sales (TTM) EV/Sales | 7.94 |
P/S ratio (TTM) P/S ratio | 8.58 |
P/B ratio (TTM) P/B ratio | 1.78 |
Revenue growth (TTM) Revenue growth | 12.41% |
Revenue (TTM) Revenue | SEK946.54m |
As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.
4 Analysts have issued a Surgical Science Sweden AB forecast:
4 Analysts have issued a Surgical Science Sweden AB forecast:
Mar '25 |
+/-
%
|
||
Revenue | 947 947 |
12%
12%
|
|
Gross Profit | 647 647 |
12%
12%
|
|
EBITDA | 191 191 |
-
|
EBIT (Operating Income) EBIT | 142 142 |
12%
12%
|
Net Profit | 141 141 |
32%
32%
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, offers a procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.
Head office | Sweden |
CEO | Mr. Englund |
Employees | 274 |
Founded | 1997 |
Website | surgicalscience.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.